Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 109

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 109
---
| • | All shareholders must be given the same information. |

| • | Those issuing documents in connection with a takeover must include statements taking responsibility for 
 the contents thereof.                                                                                   |

| • | Profit forecasts, quantified financial benefits statements and asset valuations must be made to specified 
 standards and must be reported on by professional advisers.                                               |

| • | Misleading, inaccurate or unsubstantiated statements made in documents or to the media must be publicly 
 corrected immediately.                                                                                  |

| • | Actions during the course of an offer by the offeree company, which might frustrate the offer are generally                           
 prohibited unless shareholders approve these plans. Frustrating actions would include, for example, lengthening the notice period for 
 directors under their service contract or agreeing to sell off material parts of the target group.                                    |

| • | Stringent requirements are laid down for the disclosure of dealings in relevant securities during an offer,                                 
 including the prompt disclosure of positions and dealing in relevant securities by the parties to an offer and any person who is interested 
 (directly or indirectly) in 1% or more of any class of relevant securities.                                                                 |

| • | Employees of both the offeror and the offeree company and the trustees of the offeree company’s                                         
 pension scheme must be informed about an offer. In addition, the offeree company’s employee representatives and pension scheme trustees 
 have the right to have a separate opinion on the effects of the offer on employment appended to the offeree board of directors’         
 circular or published on a website.                                                                                                     |

| 53 |

If we are deemed or become a passive foreign investment company, or PFIC, for U.S. federal income tax purposes in 2024 or in any prior or subsequent year, this may result in adverse U.S. federal income tax consequences for U.S. taxpayers that are holders of our securities.

We will be treated as a PFIC
for U.S. federal income tax purposes in any taxable year in which either (1) at least 75% of our gross income is “passive income”
or (2) on average at least 50% of our assets by value produce passive income or are held for the production of passive income. Passive
income for this purpose generally includes, among other things, certain dividends, interest, royalties, rents and gains from commodities
and securities transactions and from the sale or exchange of property that gives rise to passive income. Passive income also includes
amounts derived by reason of the